| 1 |
Lüsebrink E，Binzenhöfer L，Adamo M，et al.Cardiogenic shock ［J］.Lancet，2024，404（10466）：2006-2020.
|
| 2 |
Waksman R，Pahuja M，van Diepen S，et al.Standardized definitions for cardiogenic shock research and mechanical circulatory support devices：Scientific Expert Panel from the Shock Academic Research Consortium （SHARC） ［J］.Circulation，2023，148（14）：1113-1126.
|
| 3 |
Naidu SS，Baran DA，Jentzer JC，et al.SCAI shock stage classification expert consensus update：a review and incorporation of validation studies：this statement was endorsed by the American College of Cardiology （ACC），American College of Emergency Physicians（ACEP），American Heart Association （AHA），European Society of Cardiology （ESC） Association for Acute Cardiovascular Care （ACVC），International Society for Heart and Lung Transplantation （ISHLT），Society of Critical Care Medicine （SCCM），and Society of Thoracic Surgeons （STS） in December 2021 ［J］.J Am Coll Cardiol，2022，79（9）：933-946.
|
| 4 |
Schaubroeck H，Rossberg M，Thiele H，et al.ICU management of cardiogenic shock before mechanical support ［J］.Curr Opin Crit Care，2024，30（4）：362-370.
|
| 5 |
Shah M，Patnaik S，Patel B，et al.Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States ［J］.Clin Res Cardiol，2018，107（4）：287-303.
|
| 6 |
Papaioannou TG，Stefanadis C.Basic principles of the intraaortic balloon pump and mechanisms affecting its performance ［J］.ASAIO J，2005，51（3）：296-300.
|
| 7 |
Scheidt S，Wilner G，Mueller H，et al.Intra-aortic balloon counterpulsation in cardiogenic shock.Report of a co-operative clinical trial ［J］.N Engl J Med，1973，288（19）：979-984.
|
| 8 |
Attinger-Toller A，Bossard M，Cioffi GM，et al.Ventricular unloading using the Impella（TM） device in cardiogenic shock ［J］.Front Cardiovasc Med，2022，9：856870.
|
| 9 |
Combes A，Price S，Slutsky AS，et al.Temporary circulatory support for cardiogenic shock ［J］.Lancet，2020，396（10245）：199-212.
|
| 10 |
Glazier JJ，Kaki A.The Impella device：historical background，clinical applications and future directions ［J］.Int J Angiol，2019，28（2）：118-123.
|
| 11 |
Gottula AL，Shaw CR，Milligan J，et al.Impella in transport：physiology，mechanics，complications，and transport considerations ［J］.Air Med J，2022，41（1）：114-127.
|
| 12 |
Snipelisky D，Estep JD.Guide to temporary mechanical support in cardiogenic shock：choosing wisely ［J］.Heart Fail Clin，2024，20（4）：445-454.
|
| 13 |
Hritani AW，Wani AS，Olet S，et al.Secular trend in the use and implementation of impella in high-risk percutaneous coronary intervention and cardiogenic shock：a real-world experience ［J］.J Invasive Cardiol，2019，31（9）：e265-e270.
|
| 14 |
Salter BS，Gross CR，Weiner MM，et al.Temporary mechanical circulatory support devices：practical considerations for all stakeholders ［J］.Nat Rev Cardiol，2023，20（4）：263-277.
|
| 15 |
Kar B，Adkins LE，Civitello AB，et al.Clinical experience with the TandemHeart percutaneous ventricular assist device ［J］.Tex Heart Inst J，2006，33（2）：111-115.
|
| 16 |
Megaly M，Gandolfo C，Zakhour S，et al.Utilization of TandemHeart in cardiogenic shock：insights from the THEME registry ［J］.Catheter Cardiovasc Interv，2023，101（4）：756-763.
|
| 17 |
Baran DA，Jaiswal A，Hennig F，et al.Temporary mechanical circulatory support：devices，outcomes，and future directions ［J］.J Heart Lung Transplant，2022，41（6）：678-691.
|
| 18 |
Marbach JA，Chweich H，Miyashita S，et al.Temporary mechanical circulatory support devices：updates from recent studies ［J］.Curr Opin Cardiol，2021，36（4）：375-383.
|
| 19 |
Burkhoff D，Sayer G，Doshi D，et al.Hemodynamics of mechanical circulatory support ［J］.J Am Coll Cardiol，2015，66（23）：2663-2674.
|
| 20 |
Burkhoff D，Cohen H，Brunckhorst C，et al.A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock ［J］.Am Heart J，2006，152（3）：469.e1-8.
|
| 21 |
刘凯，苏迎，屠国伟，等.心源性休克时机械循环辅助设备的应用［J/OL］.中华重症医学电子杂志，2020，6（2）：151-155.
|
| 22 |
Kanwar MK，Everett KD，Gulati G，et al.Epidemiology and management of right ventricular-predominant heart failure and shock in the cardiac intensive care unit ［J］.Eur Heart J Acute Cardiovasc Care，2022，11（7）：584-594.
|
| 23 |
Anderson MB，Goldstein J，Milano C，et al.Benefits of a novel percutaneous ventricular assist device for right heart failure：the prospective RECOVER RIGHT study of the Impella RP device ［J］.J Heart Lung Transplant，2015，34（12）：1549-1560.
|
| 24 |
Brewer JM，Capoccia M，Maybauer DM，et al.The ProtekDuo duallumen cannula for temporary acute mechanical circulatory support in right heart failure：a systematic review ［J］.Perfusion，2023，38（1_suppl）：59-67.
|
| 25 |
Persits I，Lee R.Mechanical circulatory support in cardiogenic shock：uses in the emergency setting ［J］.Cardiol Clin，2024，42（2）：187-193.
|
| 26 |
Arora S，Atreya AR，Birati EY，et al.Temporary mechanical circulatory support as a bridge to heart transplant or durable left ventricular assist device ［J］.Interv Cardiol Clin，2021，10（2）：235-249.
|
| 27 |
Jiritano F，Lo Coco V，Matteucci M，et al.Temporary mechanical circulatory support in acute heart failure ［J］.Card Fail Rev，2020，6：e01.
|
| 28 |
Aggarwal V，Einhorn BN，Cohen HA.Current status of percutaneous right ventricular assist devices：first-in-man use of a novel dual lumen cannula ［J］.Catheter Cardiovasc Interv，2016，88（3）：390-396.
|
| 29 |
George TJ，Sheasby J，Kabra N，et al.Temporary right ventricular assist device support for acute right heart failure：a single-center experience ［J］.J Surg Res，2023，282：15-21.
|
| 30 |
Wang YH，Tsai CS，Chen JL，et al.Efficacy of a temporary CentriMag ventricular assist device in acute fulminant myocarditis patients revived with extracorporeal cardiopulmonary resuscitation ［J］.J Formos Med Assoc，2022，121（10）：1917-1928.
|
| 31 |
Chen JL，Tsai YT，Lin CY，et al.Extracorporeal life support and temporary CentriMag ventricular assist device to salvage cardiogenicshock patients suffering from prolonged cardiopulmonary resuscitation［J］.J Clin Med，2022，11（13）：3773.
|
| 32 |
Makdisi G，Wang IW.Extra corporeal membrane oxygenation （ECMO）review of a lifesaving technology ［J］.J Thorac Dis，2015，7（7）：E166-176.
|
| 33 |
Keebler ME，Haddad EV，Choi CW， et al.Venoarterial extracorporeal membrane oxygenation in cardiogenic shock ［J］.JACC Heart Fail，2018，6（6）：503-516.
|
| 34 |
Thiele H，Zeymer U，Neumann FJ，et al.Intraaortic balloon support for myocardial infarction with cardiogenic shock ［J］.N Engl J Med，2012，367（14）：1287-1296.
|
| 35 |
Thiele H，Zeymer U，Neumann FJ，et al.Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock （IABP-SHOCKⅡ）：final 12 month results of a randomised，open-label trial ［J］.Lancet，2013，382（9905）：1638-1645.
|
| 36 |
Neumann FJ，Sousa-Uva M，Ahlsson A，et al.2018 ESC/EACTS Guidelines on myocardial revascularization ［J］.Eur Heart J，2019，40（2）：87-165.
|
| 37 |
Byrne RA，Rossello X，Coughlan JJ，et al.2023 ESC Guidelines for the management of acute coronary syndromes ［J］.Eur Heart J，2023，44（38）：3720-3826.
|
| 38 |
Dhruva SS，Ross JS，Mortazavi BJ，et al.Use of mechanical circulatory support devices among patients with acute myocardial infarction complicated by cardiogenic shock ［J］.JAMA Netw Open，2021，4（2）：e2037748.
|
| 39 |
den Uil CA，Van Mieghem NM，Bastos MB，et al.Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output：a randomised trial ［J］.EuroIntervention，2019，15（7）：586-593.
|
| 40 |
Fried JA，Nair A，Takeda K，et al.Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock ［J］.J Heart Lung Transplant，2018，37（11）：1313-1321.
|
| 41 |
Bogerd M，Ten Berg S，Peters EJ，et al.Impella and venoarterial extracorporeal membrane oxygenation in cardiogenic shock complicating acute myocardial infarction ［J］.Eur J Heart Fail，2023，25（11）：2021-2031.
|
| 42 |
Thiele H，Zeymer U，Akin I，et al.Extracorporeal life support in infarct-related cardiogenic shock ［J］.N Engl J Med，2023，389（14）：1286-1297.
|
| 43 |
Banning AS，Sabaté M，Orban M，et al.Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction：the multicentre，randomised EURO SHOCK trial ［J］.EuroIntervention，2023，19（6）：482-492.
|
| 44 |
Ostadal P，Rokyta R，Karasek J，et al.Extracorporeal membrane oxygenation in the therapy of cardiogenic shock：results of the ECMOCS randomized clinical trial ［J］.Circulation，2023，147（6）：454-464.
|
| 45 |
Lüsebrink E，Binzenhöfer L，Hering D，et al.Scrutinizing the role of venoarterial extracorporeal membrane oxygenation：has clinical practice outpaced the evidence? ［J］.Circulation，2024，149（13）：1033-1052.
|
| 46 |
Cheng R，Hachamovitch R，Kittleson M，et al.Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest：a meta-analysis of 1，866 adult patients ［J］.Ann Thorac Surg，2014，97（2）：610-616.
|
| 47 |
Damluji AA，Tehrani B，Sinha SS，et al.Position statement on vascular access safety for percutaneous devices in AMI complicated by cardiogenic shock ［J］.JACC Cardiovasc Interv，2022，15（20）：2003-2019.
|
| 48 |
Stretch R，Sauer CM，Yuh DD，et al.National trends in the utilization of short-term mechanical circulatory support：incidence，outcomes，and cost analysis ［J］.J Am Coll Cardiol，2014，64（14）：1407-1415.
|
| 49 |
Whitman GJ.Extracorporeal membrane oxygenation for the treatment of postcardiotomy shock ［J］.J Thorac Cardiovasc Surg，2017，153（1）：95-101.
|
| 50 |
Gouveia D，Máximo J，Costa N，et al.ECMO post-cardiotomy，a single centre experience ［J］.Port J Card Thorac Vasc Surg，2021，28（1）：19-23.
|
| 51 |
Carvalho Guerra N.Post-cardiotomy ECMO：time for hope or time for despair? ［J］.Port J Card Thorac Vasc Surg，2021，28（1）：13-14.
|
| 52 |
Lorusso R，Whitman G，Milojevic M，et al.2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients ［J］.Eur J Cardiothorac Surg，2021，59（1）：12-53.
|
| 53 |
Yannopoulos D，Bartos J，Raveendran G，et al.Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation （ARREST）：a phase 2，single centre，open-label，randomised controlled trial ［J］.Lancet，2020，396（10265）：1807-1816.
|
| 54 |
Belohlavek J，Smalcova J，Rob D，et al.Effect of intra-arrest transport，extracorporeal cardiopulmonary resuscitation，and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest：a randomized clinical trial ［J］.JAMA，2022，327（8）：737-747.
|
| 55 |
Suverein MM，Delnoij T，Lorusso R，et al.Early extracorporeal CPR for refractory out-of-hospital cardiac arrest ［J］.N Engl J Med，2023，388（4）：299-309.
|
| 56 |
Grunau B，Kime N，Leroux B，et al.Association of intra-arrest transport vs continued on-scene resuscitation with survival to hospital discharge among patients with out-of-hospital cardiac arrest ［J］.JAMA，2020，324（11）：1058-1067.
|
| 57 |
Linde L，Mørk SR，Gregers E，et al.Selection of patients for mechanical circulatory support for refractory out-of-hospital cardiac arrest ［J］.Heart，2023，109（3）：216-222.
|
| 58 |
Møller JE，Engstrøm T，Jensen LO，et al.Microaxial flow pump or standard care in infarct-related cardiogenic shock ［J］.N Engl J Med，2024，390（15）：1382-1393.
|
| 59 |
Griffith BP，Anderson MB，Samuels LE，et al.The RECOVER I：a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support ［J］.J Thorac Cardiovasc Surg，2013，145（2）：548-554.
|